Streetbeat News

Regulatory

TVGN

Tevogen Bio, a biotech company listed on NASDAQ, is making strides in developing T cell therapeutics for infectious diseases and cancers. The company recently met with Congress to discuss its ExacTcell technology as a solution for Long COVID. Tevogen Bio has achieved significant milestones, including positive clinical trial results for its lead product, TVGN 489, and a robust intellectual property portfolio. The company is now publicly traded and included in the Russell 3000 Index.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:13 pm

AIMD

AIMDW

Ainos, Inc. is set to begin a clinical study for VELDONA® in treating Sjogren's syndrome in December 2024 in Taiwan. The study aims to evaluate the drug's effectiveness in improving saliva secretion and dryness symptoms. Previous U.S. Phase 3 data showed significant benefits.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:08 pm

FXI

PVH

China has initiated an investigation into PVH Corp., a U.S. company, over alleged discrimination against products related to Xinjiang. The probe is based on suspected violations of market principles.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:07 pm

EBS

Los Angeles County reports a doubling of mpox cases, urging vaccinations for high-risk groups. The JYNNEOS vaccine is available at pharmacies and public health clinics. Health officials recommend safe sex practices and testing for symptoms.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 3:06 pm

JD

JD.com shares rose over 9% due to China's Central Bank's new stimulus package, including a 50-basis-point cut to the reserve requirement ratio, injecting liquidity into the economy. This move is expected to boost consumer spending and benefit JD.com significantly.

Portfolio Pulse from Henry Khederian

September 24, 2024 | 3:02 pm

PVH

PVH Corp. is in contact with China's Ministry of Commerce, which could have implications for its business operations in China. This development may affect investor sentiment towards PVH, as China is a significant market for the company.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 2:57 pm

SPY

SEC Chair Gary Gensler testified before the House Financial Services Committee, discussing regulatory issues that could impact financial markets. The testimony may influence market sentiment and regulatory outlook.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 2:46 pm

TCOM

Trip.com Group Ltd (NASDAQ:TCOM) shares rose by 5.4% following the Chinese Central Bank's announcement of a new stimulus package, including a 50-basis-point cut to the reserve requirement ratio. This monetary easing is expected to boost consumer and corporate spending on travel, benefiting Trip.com.

Portfolio Pulse from Henry Khederian

September 24, 2024 | 2:45 pm

FXI

China's financial regulator is encouraging banks to support loan renewals for borrowers facing temporary financial difficulties. Medium-sized firms with working capital loans due by September 30, 2027, may receive renewal support similar to that available for small and micro firms.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 2:43 pm

FXI

SPY

China's financial regulator is urging financial institutions to optimize loan services for small and medium-sized enterprises (SMEs) by adjusting loan terms, diversifying repayment options, and expanding credit fund coverage.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 2:39 pm